Page last updated: 2024-09-04

ro 15-0216 and aclarubicin

ro 15-0216 has been researched along with aclarubicin in 1 studies

Compound Research Comparison

Studies
(ro 15-0216)
Trials
(ro 15-0216)
Recent Studies (post-2010)
(ro 15-0216)
Studies
(aclarubicin)
Trials
(aclarubicin)
Recent Studies (post-2010) (aclarubicin)
120082697105

Protein Interaction Comparison

ProteinTaxonomyro 15-0216 (IC50)aclarubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)9.9
5-hydroxytryptamine receptor 2BHomo sapiens (human)1.106

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alsner, J; Andersen, AH; Jensen, PB; Sinding, J; Sørensen, BS; Westergaard, O1

Other Studies

1 other study(ies) available for ro 15-0216 and aclarubicin

ArticleYear
Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events.
    Journal of molecular biology, 1992, Dec-05, Volume: 228, Issue:3

    Topics: Acetanilides; Aclarubicin; Amsacrine; Animals; Base Sequence; Cattle; DNA Topoisomerases, Type II; Molecular Sequence Data; Nitroimidazoles; Nucleic Acid Conformation; Nucleic Acid Hybridization; Oligodeoxyribonucleotides; Thymus Gland; Topoisomerase II Inhibitors; Trypanocidal Agents

1992